Drimva

Flagship Pioneering

Etiome: Translational Biology / Target Validation Co-Op

Cambridge, MA USA +1 · Internship · Posted Oct 22, 2026

Location
Cambridge, MA USA
Etiome, Inc.
Education
Currently enrolled in an undergraduate or master program in Biology, Molecular Biology, Cell Biology, Biochemistry, Biotechnology, Biomedical Engineering, Pharmacology, or a related discipline.

About the job

Conduct cell-based experiments and analyze mechanistic data to validate therapeutic targets and support drug discovery programs.

What you'll do

  • Design, develop, and perform disease-relevant in vitro assays, including mammalian cell culture and target-perturbation experiments.
  • Use molecular and cellular biology techniques, analyze results, and integrate experimental readouts against target-validation criteria.
  • Review scientific literature, document experiments, and present findings to Biology and project teams.

What they ask for

  • Currently enrolled in an undergraduate or master program in a related discipline.
  • Strong molecular and cellular biology foundation and hands-on laboratory research or prior co-op experience.
  • Experience with mammalian cell culture and hands-on experience with one or more listed molecular, immunoassay, or cell-based techniques.
  • Ability to troubleshoot experiments and critically evaluate results; strong attention to detail and rigorous, reproducible work.

Nice to have

  • Research experience in disease biology, functional genomics, target validation, or drug discovery.
  • Experience with gene perturbation approaches such as siRNA or CRISPR, or developing and optimizing cell-based assays.

Pay

$25 - $35 per hour (base salary)

Tools

mammalian cell culture, qPCR, RNA isolation, cDNA synthesis, ELISA, MSD-based immunoassays, Western blotting, CRISPR

AI focus

Applicant data may be reviewed using AI-assisted screening tools; the role itself involves no stated AI work.

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 6, 2026 (UTC)